CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +39,072 | 39,072 | ||
| 2023-06-13 | McKee Amy E Director | Grant or award | +16,745 | 29,611 | ||
| 2023-06-13 | McKee Amy E Director | Grant or award · Automatic Stock Option Grant | +39,072 | 39,072 | ||
| 2023-06-13 | HEGGIE THERESA Director | Grant or award | +16,745 | 49,114 | ||
| 2023-06-13 | HEGGIE THERESA Director | Grant or award · Automatic Stock Option Grant | +39,072 | 39,072 | ||
| 2023-06-13 | ABERCROMBIE GEORGE B Director | Grant or award | +16,745 | 29,611 | ||
| 2023-06-13 | ABERCROMBIE GEORGE B Director | Grant or award · Automatic Stock Option Grant | +39,072 | 39,072 | ||
| 2023-05-31 | MILANO VINCENT Director | Grant or award | +680 | $8.27 | $6K | 32,506 |
| 2023-05-31 | LEVIN ALAN G Director | Grant or award | +1,360 | $8.27 | $11K | 20,345 |
| 2023-05-31 | HEGGIE THERESA Director | Grant or award | +680 | $8.27 | $6K | 32,369 |
| 2023-04-03 | Thackray Helen M. Chief R&D Officer | Sale 10b5-1 | −7,000 | $8.29 | $58K | 207,275 |
| 2023-03-21 | Stonehouse Jon P President & CEO | Option exercise | +31,055 | $3.22 | $100K | 1,039,794 |
| 2023-03-21 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −31,055 | 305,995 | ||
| 2023-02-28 | MILANO VINCENT Director | Grant or award | +635 | $8.85 | $6K | 31,826 |
| 2023-02-28 | INGRAM ROBERT ALEXANDER Director | Grant or award | +2,259 | $8.85 | $20K | 100,198 |
| 2023-02-28 | HEGGIE THERESA Director | Grant or award | +635 | $8.85 | $6K | 31,689 |
| 2023-02-28 | LEVIN ALAN G Director | Grant or award | +1,271 | $8.85 | $11K | 18,985 |
| 2023-02-01 | Stonehouse Jon P President & CEO | Option exercise | +100,000 | $5.45 | $545K | 1,108,739 |
| 2023-02-01 | Stonehouse Jon P President & CEO | Sale | −100,000 | $10.38 | $1.0M | 1,008,739 |
| 2023-02-01 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −100,000 | 0 |
Page 12 of 18 · 357 trades